PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 174 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2017. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,520,000 | +90.7% | 39,179 | 0.0% | 0.02% | +58.3% |
| Q4 2018 | $797,000 | -68.4% | 39,179 | -28.8% | 0.01% | -62.5% |
| Q3 2018 | $2,524,000 | -33.9% | 55,048 | -14.8% | 0.03% | -39.6% |
| Q2 2018 | $3,820,000 | +135.1% | 64,585 | +170.4% | 0.05% | +112.0% |
| Q1 2018 | $1,625,000 | -24.8% | 23,882 | +9.3% | 0.02% | -19.4% |
| Q4 2017 | $2,160,000 | -24.2% | 21,856 | -8.1% | 0.03% | -22.5% |
| Q3 2017 | $2,849,000 | -18.2% | 23,792 | -40.3% | 0.04% | -24.5% |
| Q2 2017 | $3,481,000 | +180.5% | 39,834 | +19.4% | 0.05% | +152.4% |
| Q1 2017 | $1,241,000 | +34.7% | 33,369 | +11.2% | 0.02% | +16.7% |
| Q4 2016 | $921,000 | -54.2% | 30,000 | 0.0% | 0.02% | -48.6% |
| Q3 2016 | $2,012,000 | – | 30,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,400,000 | $25,032,000 | 1.43% |
| TANG CAPITAL MANAGEMENT LLC | 1,365,376 | $14,241,000 | 1.38% |
| Palo Alto Investors LP | 1,343,897 | $14,017,000 | 0.84% |
| Sofinnova Investments, Inc. | 1,197,630 | $12,491,000 | 0.79% |
| Gyon Technologies Capital Management, LP | 29,745 | $310,000 | 0.75% |
| RICE HALL JAMES & ASSOCIATES, LLC | 455,567 | $4,752,000 | 0.20% |
| GLOBEFLEX CAPITAL L P | 63,226 | $659,000 | 0.17% |
| PDT Partners, LLC | 188,538 | $1,966,000 | 0.13% |
| CADENCE CAPITAL MANAGEMENT LLC | 71,179 | $742,000 | 0.11% |
| FRED ALGER MANAGEMENT, LLC | 2,474,029 | $25,804,000 | 0.08% |